PRKCA and cystic fibrosis: PRKCA has also been shown to be associated with numerous other infections, including infections by Staphylococcus aureus (26); with progression of sepsis (27) and toxoplasmosis (28); with Burkholderia cenocepacia infections in cystic fibrosis patients (29); and with hepatitis E virus replication (30).